Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?
Sign Up to like & getrecommendations! Published in 2025 at "European heart journal"
DOI: 10.1093/eurheartj/ehaf718
Abstract: Antiplatelet therapy is the cornerstone of treatment in patients with established atherosclerotic disease. The use of a single antiplatelet agent is commonly recommended for the long-term management of these patients. Although aspirin has represented the… read more here.
Keywords: disease; aspirin p2y12; aspirin; inhibitor monotherapy ... See more keywords